Guangzhou Baiyunshan Phar... (GZPHF)

PNK: GZPHF · Real-Time Price · USD

2.44

0.19 (8.44%)

At close: May 02, 2025, 1:42 PM

Guangzhou Baiyunshan Pharmaceutical Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	22.47B	15.93B	18.02B	18.1B	22.95B	17.24B	18.21B	18.34B	21.63B	15.98B	17.59B	16.68B	20.54B	15.47B	17.41B	16.08B	20.05B	14.79B	16.41B	13.49B	16.98B	14.89B	16.72B	15.29B	18.06B	12.36B	15.04B	7.93B	6.91B	4.99B	4.85B	5.83B	5.29B	4.49B	4.69B	5.81B	5.05B
Cost of Revenue	17.86B	13.87B	15.36B	15.38B	17.87B	14.97B	14.87B	15.05B	16.59B	13.54B	14.45B	13.81B	15.7B	13.08B	14.11B	13.06B	15.54B	13.46B	13.33B	11.19B	13.25B	12.89B	13.29B	12.35B	13.55B	9.93B	12.18B	5.8B	4.25B	3B	3.1B	3.75B	3.21B	3.57B	3.11B	3.69B	3.05B
Gross Profit	4.61B	2.06B	2.66B	2.72B	5.08B	2.26B	3.35B	3.29B	5.04B	2.44B	3.13B	2.87B	4.84B	2.4B	3.3B	3.03B	4.5B	1.32B	3.09B	2.3B	3.73B	2B	3.43B	2.94B	4.51B	2.43B	2.85B	2.13B	2.66B	1.98B	1.75B	2.08B	2.08B	923.58M	1.58B	2.12B	2B
Operating Income	2.23B	-404.67M	774.97M	773.84M	2.45B	220.93M	1.22B	1.18B	2.35B	613.11M	1.13B	1.07B	2.26B	523.63M	1.02B	1.21B	2.04B	216.88M	1.2B	743.19M	1.52B	87.04M	791.16M	1.41B	1.77B	27.87M	825.75M	1.86B	1.13B	710.63M	387.85M	798.87M	563.63M	362.06M	218.89M	392.08M	493.59M
Interest Income	48.08M	80.53M	45.61M	406.33M	128.17M	99.26M	117.37M	420.21M	149.25M	1.12B	139.81M	590.83M	236.02M	1.01B	158.55M	447.01M	161M	657.25M	90.95M	303.6M	111.18M	523.41M	79.91M	209.2M	68.92M	477.93M	111.2M	n/a	60.4M	n/a	28.65M	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	2.23B	-398.46M	776.63M	777.06M	2.45B	345.8M	1.22B	1.18B	2.35B	586.29M	1.12B	1.07B	2.26B	518.03M	1.02B	1.15B	2.04B	263.24M	1.21B	744.4M	1.52B	77.54M	839.23M	1.44B	1.77B	38.01M	969.56M	1.87B	1.14B	693.25M	399.3M	810.57M	589.86M	605.59M	280.32M	545.33M	513.81M
Net Income	1.82B	-323.48M	609.41M	591.45M	1.96B	264.43M	980M	902.65M	1.91B	492.16M	884.37M	784.36M	1.81B	408.14M	809.36M	874.96M	1.63B	256.18M	894.8M	580.41M	1.18B	29.36M	611.96M	1.14B	1.41B	1.69M	820.29M	1.71B	905.17M	576M	327.51M	673.48M	484.66M	451.61M	224.62M	422.49M	409.32M
Selling & General & Admin	2.19B	-2.99B	4.34B	851.04M	2.53B	1.84B	2.94B	1.04B	2.5B	383.32M	2.62B	1.03B	2.4B	389.36M	2.84B	890.97M	2.31B	-181.86M	1.74B	824.6M	1.99B	353.72M	2.42B	1B	2.47B	786.56M	1.94B	766.98M	1.63B	304.52M	1.39B	833.2M	1.58B	-546.65M	1.38B	1.22B	1.56B
Research & Development	143.71M	185.26M	187.37M	205.01M	186.14M	192.03M	178.91M	221.18M	179.39M	155.07M	223.07M	202.44M	238.88M	270.01M	218.81M	199.78M	186.12M	208.84M	134.25M	134.74M	134.11M	112.74M	186.96M	105.36M	171.46M	193.23M	149.98M	105.99M	136.29M	502.33M	110.48M	133.76M	n/a	330.37M	n/a	153.05M	n/a
Other Expenses	46.1M	5.27B	-2.65B	3.22M	91.02K	-7.22M	-47.29M	41.23M	63.55M	1.61B	-795.7M	583.34M	80.66M	191.28M	4.8M	-66.38M	4.21M	37.89M	14.82M	-22.32M	4.27M	22.12M	48.07M	41.8M	3.97M	125.71M	143.81M	263.09M	17.05M	-20.31M	12.06M	11.3M	26.61M	244.62M	61.79M	152.64M	20.54M
Operating Expenses	2.38B	2.47B	1.88B	2.03B	2.68B	2.04B	2.15B	2.22B	2.74B	2.15B	2.04B	1.82B	2.72B	2.07B	2.34B	1.89B	2.56B	1.38B	1.91B	1.48B	2.19B	1.91B	2.65B	1.53B	2.72B	2.12B	2.14B	1.46B	1.69B	1.5B	1.42B	1.39B	1.64B	629.01M	1.41B	1.8B	1.6B
Interest Expense	101.61M	100.68M	104.13M	106.91M	106.43M	113.18M	107.56M	113.73M	111.73M	124.12M	102.34M	101.51M	106.44M	108.62M	105.42M	120.74M	83.05M	116.29M	70.55M	100.65M	86.49M	88.84M	109.39M	107.83M	95.57M	70.42M	132.66M	88.81M	2.43M	119.82M	1.01M	30.08M	n/a	41.52M	25.17M	22.2M	n/a
Selling & Marketing Expenses	1.59B	-1.8B	2.85B	1.23B	1.89B	1.4B	1.44B	1.4B	1.87B	1.41B	1.28B	1.31B	1.87B	1.38B	1.57B	1.2B	1.8B	681.56M	1.27B	1.08B	1.55B	1.24B	1.96B	1.27B	1.91B	1.41B	1.47B	1.04B	1.13B	1.09B	959.78M	1.03B	1.21B	198.4M	996.51M	1.44B	1.19B
Cost & Expenses	20.25B	16.34B	17.24B	17.4B	20.55B	17.01B	17.02B	17.27B	19.33B	15.7B	16.5B	15.63B	18.42B	15.14B	16.45B	14.94B	18.1B	14.84B	15.23B	12.67B	15.45B	14.8B	15.94B	13.88B	16.27B	12.05B	14.33B	7.27B	5.93B	4.51B	4.52B	5.14B	4.85B	4.2B	4.52B	5.49B	4.65B
Income Tax Expense	373.54M	-109.75M	155.23M	140.75M	420.62M	27.46M	212.76M	225.02M	385.93M	17.65M	188.92M	211.06M	372.24M	58.22M	156.1M	202.05M	337.72M	5.28M	262.51M	117.89M	261.76M	16.37M	136.92M	225.35M	308.6M	13.61M	119.61M	134.89M	216.91M	103.61M	61.15M	123.05M	86.4M	144.18M	46.2M	105.9M	90.11M
Shares Outstanding (Basic)	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.62B	1.62B	1.63B	1.63B	1.59B	1.59B	1.63B	1.63B	1.61B	1.62B	1.63B	1.63B	1.61B	1.64B	1.63B	1.63B	1.32B	1.32B	1.29B	1.29B
Shares Outstanding (Diluted)	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.63B	1.62B	1.62B	1.63B	1.63B	1.59B	1.59B	1.63B	1.63B	1.61B	1.62B	1.63B	1.63B	1.64B	1.64B	1.63B	1.63B	1.32B	1.32B	1.29B	1.29B
EPS (Basic)	1.12	-0.2	0.37	0.36	1.20	0.16	0.60	0.56	1.17	0.30	0.54	0.48	1.11	0.28	0.50	0.54	1.00	0.16	0.55	0.36	0.73	0.02	0.39	0.70	0.87	0.00	0.51	1.05	0.56	0.35	0.20	0.41	0.30	0.34	0.17	0.33	0.32
EPS (Diluted)	1.12	-0.2	0.37	0.36	1.20	0.16	0.60	0.56	1.17	0.30	0.54	0.48	1.11	0.28	0.50	0.54	1.00	0.16	0.55	0.36	0.73	0.02	0.39	0.70	0.87	0.00	0.51	1.05	0.56	0.35	0.20	0.41	0.30	0.34	0.17	0.33	0.32
EBITDA	2.33B	-297.78M	880.76M	883.98M	2.78B	682.24M	1.53B	1.53B	2.7B	866.26M	1.42B	1.32B	2.53B	845.04M	1.28B	1.36B	2.25B	252.73M	1.28B	816.27M	1.61B	252.03M	948.62M	1.36B	1.87B	544.58M	1.11B	1.83B	981.02M	1.04B	333.02M	816.89M	460.67M	1.09B	163.1M	672.42M	396.76M
EBIT	2.33B	-297.78M	880.76M	883.98M	2.56B	471.25M	1.33B	1.29B	2.47B	710.41M	1.23B	1.17B	2.37B	626.65M	1.12B	1.27B	2.12B	312.8M	1.28B	816.27M	1.61B	112.21M	948.62M	1.36B	1.87B	-118.91M	1.1B	2.06B	1.14B	1.04B	400.11M	958.93M	460.67M	584.54M	252.19M	672.42M	396.76M
Depreciation & Amortization	n/a	n/a	105.79M	129.89M	152.81M	223.26M	223.26M	269.4M	269.4M	209.87M	209.87M	186.96M	186.96M	187.12M	187.12M	173.15M	173.15M	97.23M	95.13M	95.76M	95.13M	95.13M	75.31M	104.83M	75.31M	516.71M	277.1M	238.31M	-145.31M	350.18M	-54.83M	162.89M	-123.7M	734.01M	-56.64M	279.18M	-90.39M